Skip to search formSkip to main contentSkip to account menu

KAG-308

Known as: 3,3-difluorohexahydro-4-((1E,3R,4R)-3-hydroxyl-4-(3-methylphenyl)-1-penten-1-yl)-2-(4-(1H-tetrazol-5-yl)butylidene)-2H-cyclopenta(b)furan-5-ol 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Epoprostenol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Kag-308, a Novel Orally Active EP4 Agonist, Ameliorates Mucosal Injury on Endoscopic Examination in a Chronic Colitis Model
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)